Functional characterization of a first avian cytochrome P450 of the CYP2d subfamily (CYP2D49)

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Cai, Hua ^a   Jiang, Jun ^a   Yang, Qi ^a   Chen, Qingmei ^a   Deng, Yiqun ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; COMPLEMENTARY DNA; CYTOCHROME P450 2D; CYTOCHROME P450 2D49; CYTOCHROME P450 2D6; DEBRISOQUINE; QUINIDINE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANTISERUM; CYTOCHROME P450; ETHANOLAMINE DERIVATIVE; ISOENZYME;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CHICKEN; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOCHROME P450 2D49 GENE; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; GENE STRUCTURE; GENOME ANALYSIS; HELA CELL; HETEROLOGOUS EXPRESSION; HYDROXYLATION; KIDNEY; LIVER; METABOLISM; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN CONFORMATION; SITE DIRECTED MUTAGENESIS; SMALL INTESTINE; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MOLECULAR GENETICS; MULTIGENE FAMILY; PHYLOGENY; SEQUENCE HOMOLOGY;

ANIMALIA; AVES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; CHICKENS; CIRCULAR DICHROISM; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; ETHANOLAMINES; FEMALE; HELA CELLS; HUMANS; IMMUNE SERA; ISOENZYMES; LIVER; MALE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHYLOGENY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84861902895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038395     Document Type: Article

References (53)

1. Anzenbacher P, Anzenbacherova E, (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58: 737-747.
2. Zuber R, Anzenbacherova E, Anzenbacher P, (2002) Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 6: 189-198.
3. Niwa T, Murayama N, Yamazaki H, (2011) Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 12: 412-435.
4. Zhou SF, (2009) Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet 48: 689-723.
5. Zhou SF, (2009) Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet 48: 761-804.
6. Sakuyama K, Sasaki T, Ujiie S, Obata K, Mizugaki M, et al. (2008) Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57). Drug Metab Dispos 36: 2460-2467.
7. Yu AM, Idle JR, Gonzalez FJ, (2004) Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab Rev 36: 243-277.
8. de Graaf C, Oostenbrink C, Keizers PH, van Vugt-Lussenburg BM, van Waterschoot RA, et al. (2007) Molecular modeling-guided site-directed mutagenesis of cytochrome P450 2D6. Curr Drug Metab 8: 59-77.
9. Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, et al. (2006) Crystal structure of human cytochrome P450 2D6. J Biol Chem 281: 7614-7622.
10. Gonzalez FJ, Matsunaga T, Nagata K, Meyer UA, Nebert DW, et al. (1987) Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 6: 149-161.
11. Matsunaga E, Umeno M, Gonzalez FJ, (1990) The rat P450 IID subfamily: complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme-binding region of the cytochrome P450 active site. J Mol Evol 30: 155-169.
12. Suzuki T, Narimatsu S, Fujita S, Masubuchi Y, Umeda S, et al. (1992) Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metab Dispos 20: 367-373.
13. Hiroi T, Chow T, Imaoka S, Funae Y, (2002) Catalytic specificity of CYP2D isoforms in rat and human. Drug Metab Dispos 30: 970-976.
14. Wong G, Kawajiri K, Negishi M, (1987) Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16) alpha) in mouse liver: cDNA sequences, neonatal imprinting, and reversible regulation by androgen. Biochemistry 26: 8683-8690.
15. Wong G, Itakura T, Kawajiri K, Skow L, Negishi M, (1989) Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16 alpha)) in mice. Organization, differential regulation, and chromosome localization. J Biol Chem 264: 2920-2927.
16. Jiang Q, Voigt JM, Colby HD, (1995) Molecular cloning and sequencing of a guinea pig cytochrome P4502D (CYP2D16): high level expression in adrenal microsomes. Biochem Biophys Res Commun 209: 1149-1156.
17. Sakamoto K, Kirita S, Baba T, Nakamura Y, Yamazoe Y, et al. (1995) A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Arch Biochem Biophys 319: 372-382.
18. Tasaki T, Iwata H, Kazusaka A, Fujita S, (1998) Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15. J Biochem 123: 747-751.
19. Tsuneoka Y, Matsuo Y, Higuchi R, Ichikawa Y, (1992) Characterization of the cytochrome P-450IID subfamily in bovine liver. Nucleotide sequences and microheterogeneity. Eur J Biochem 208: 739-746.
20. Yamamoto Y, Ishizuka M, Takada A, Fujita S, (1998) Cloning, tissue distribution, and functional expression of two novel rabbit cytochrome P450 isozymes, CYP2D23 and CYP2D24. J Biochem 124: 503-508.
21. Hichiya H, Takemi C, Tsuzuki D, Yamamoto S, Asaoka K, et al. (2002) Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver. Biochem Pharmacol 64: 1101-1110.
22. Hichiya H, Kuramoto S, Yamamoto S, Shinoda S, Hanioka N, et al. (2004) Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19. Biochem Pharmacol 68: 165-175.
23. Perrins, Christopher B, (2003) Encyclopædia Britannica: Firely Encyclopædia of birds. New York Firefly Books, Ltd.
24. Gilday D, Gannon M, Yutzey K, Bader D, Rifkind AB, (1996) Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 271: 33054-33059.
25. Ourlin JC, Baader M, Fraser D, Halpert JR, Meyer UA, (2000) Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37). Arch Biochem Biophys 373: 375-384.
26. Baader M, Gnerre C, Stegeman JJ, Meyer UA, (2002) Transcriptional activation of cytochrome P450 CYP2C45 by drugs is mediated by the chicken xenobiotic receptor (CXR) interacting with a phenobarbital response enhancer unit. J Biol Chem 277: 15647-15653.
27. Khalil WF, Saitoh T, Shimoda M, Kokue E, (2001) In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens. J Vet Pharmacol Ther 24: 343-348.
28. Nelson DR, (2006) Cytochrome P450 nomenclature, 2004. Methods Mol Biol 320: 1-10.
29. Gut J, Catin T, Dayer P, Kronbach T, Zanger U, et al. (1986) Debrisoquine/sparteine-type polymorphism of drug oxidation. Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J Biol Chem 261: 11734-11743.
30. Martignoni M, Groothuis GM, de Kanter R, (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2: 875-894.
31. Roussel F, Duignan DB, Lawton MP, Obach RS, Strick CA, et al. (1998) Expression and characterization of canine cytochrome P450 2D15. Arch Biochem Biophys 357: 27-36.
32. Greenfield NJ, (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1: 2876-2890.
33. Mura C, Broyart JP, Jacqz E, Elion J, Krishnamoorthy R, (1991) NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus. Nucleic Acids Res 19: 1162.
34. Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, et al. (1996) Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics 6: 319-328.
35. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, et al. (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14: 1-18.
36. Handschin C, Meyer UA, (2000) A conserved nuclear receptor consensus sequence (DR-4) mediates transcriptional activation of the chicken CYP2H1 gene by phenobarbital in a hepatoma cell line. J Biol Chem 275: 13362-13369.
37. Handschin C, Podvinec M, Stockli J, Hoffmann K, Meyer UA, (2001) Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. Mol Endocrinol 15: 1571-1585.
38. Okey AB, (1992) Enzyme induction in the cytochrome P450 system. In: Kalow W, editors. Pharmacogenetics of Drug Metabolism pp. 594-608.
39. Masuda K, Tamagake K, Okuda Y, Torigoe F, Tsuzuki D, et al. (2005) Change in enantioselectivity in bufuralol 1″-hydroxylation by the substitution of phenylalanine-120 by alanine in cytochrome P450 2D6. Chirality 17: 37-43.
40. Al-Dabbagh SG, Idle JR, Smith RL, (1981) Animal modelling of human polymorphic drug oxidation-the metabolism of debrisoquine and phenacetin in rat inbred strains. J Pharm Pharmacol 33: 161-164.
41. Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, et al. (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30: 1131-1152.
42. Paine MJ, McLaughlin LA, Flanagan JU, Kemp CA, Sutcliffe MJ, et al. (2003) Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. J Biol Chem 278: 4021-4027.
43. Ellis SW, Hayhurst GP, Smith G, Lightfoot T, Wong MM, et al. (1995) Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J Biol Chem 270: 29055-29058.
44. Keizers PH, Lussenburg BM, de Graaf C, Mentink LM, Vermeulen NP, et al. (2004) Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism. Biochem Pharmacol 68: 2263-2271.
45. Flanagan JU, Marechal JD, Ward R, Kemp CA, McLaughlin LA, et al. (2004) Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite. Biochem J 380: 353-360.
46. Hayhurst GP, Harlow J, Chowdry J, Gross E, Hilton E, et al. (2001) Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6. Biochem J 355: 373-379.
47. Wan J, Imaoka S, Chow T, Hiroi T, Yabusaki Y, et al. (1997) Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Arch Biochem Biophys 348: 383-390.
48. Narimatsu S, Kazamori D, Masuda K, Katsu T, Funae Y, et al. (2009) The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol. Biochem Pharmacol 77: 920-931.
49. Michael PP, Lesley M, Thomas FE, (2005) Establishment of Functional Human Cytochrome P450 Monooxygenase Systems in Escherichia coil. In: Phillips IR, Shephard EA, editors. Cytochrome P450 Protocols (Methods in Molecular Biology), 2nd edition pp. 19-29.
50. Hadidi S, Yu K, Chen Z, Gorczynski RM, (2001) Preparation and functional properties of polyclonal and monoclonal antibodies to murine MD-1. Immunol Lett 77: 97-103.
51. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
52. Woolhouse NM, Andoh B, Mahgoub A, Sloan TP, Idle JR, et al. (1979) Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians. Clin Pharmacol Ther 26: 584-591.
53. Chen YH, Yang JT, Chau KH, (1974) Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 13: 3350-3359.